Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-3 of 3
Keywords: HCC
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Sequential Systemic Treatment in Advanced Hepatocellular Carcinoma Is Able to Prolong Median Survival to More than 3 Years in a Selected Real-World Cohort
Available to PurchaseJohann von Felden, Kathrin Karkmann, Harald Ittrich, Ines Gil-Ibanez, Thorben Fründt, Jenny Krause, Ansgar W. Lohse, Henning Wege, Kornelius Schulze
Journal:
Visceral Medicine
Visc Med (2021) 37 (2): 87–93.
Published Online: 07 May 2020
...Johann von Felden; Kathrin Karkmann; Harald Ittrich; Ines Gil-Ibanez; Thorben Fründt; Jenny Krause; Ansgar W. Lohse; Henning Wege; Kornelius Schulze Introduction: The number of efficacious systemic agents for advanced hepatocellular carcinoma (HCC) has rapidly increased over the past 3 years...
Journal Articles
Management of HBV and HBV/HDV-Associated Liver Cirrhosis
Available to Purchase
Journal:
Visceral Medicine
Viszeralmedizin (2016) 32 (2): 86–94.
Published Online: 12 April 2016
...Christoph Höner zu Siederdissen; Markus Cornberg Summary Background: Chronic hepatitis B virus (HBV) infection and hepatitis delta virus (HDV) co-infection lead to liver cirrhosis, hepatic decompensation, and hepatocellular carcinoma (HCC). Methods: We review the current knowledge of the management...
Journal Articles
Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis
Available to Purchase
Journal:
Visceral Medicine
Viszeralmedizin (2016) 32 (2): 121–126.
Published Online: 05 April 2016
...Christoph Roderburg; Frank Tacke; Christian Trautwein Summary Background: Chronic hepatitis B and C infections represent major risk factors for the development of hepatocellular carcinoma (HCC). Recently, the management of patients with viral hepatitis has dramatically changed. In the present...
